Contact
searchSearch
HMP Global

HIV/AIDS Topic Center

Featured Article

News
Addressing Stigma is Essential for Increasing PrEP Uptake and Adherence in HIV Prevention Efforts
09/20/2024
Addressing stigma associated with pre-exposure prophylaxis (PrEP) is crucial for improving its uptake and adherence among eligible populations, according to study results published in Sexes.
Addressing stigma associated with pre-exposure prophylaxis (PrEP) is crucial for improving its uptake and adherence among eligible populations, according to study results published in Sexes.
Addressing stigma associated...
09/20/2024
First Report Managed Care
News
CDC Invests $400 Million to Accelerate HIV Prevention and Surveillance Efforts Nationwide
09/16/2024
The Centers for Disease Control and Prevention (CDC) has awarded $400 million in funding to boost HIV prevention and surveillance efforts across the United States, aiming to accelerate progress in reducing new infections and improving health...
The Centers for Disease Control and Prevention (CDC) has awarded $400 million in funding to boost HIV prevention and surveillance efforts across the United States, aiming to accelerate progress in reducing new infections and improving health...
The Centers for Disease Control...
09/16/2024
First Report Managed Care
News
HIV Cases Rise Among Gay Latinos
07/24/2024
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise...
07/24/2024
First Report Managed Care
News
Machine Learning Approach Identifies HIV-1 Broadly Neutralizing Antibodies
07/10/2024
A computational method has been developed to identify HIV-1 broadly neutralizing antibodies (bNAbs) from non-selected immune repertoires, researchers reported in the journal Nature Communications.
A computational method has been developed to identify HIV-1 broadly neutralizing antibodies (bNAbs) from non-selected immune repertoires, researchers reported in the journal Nature Communications.
A computational method has been...
07/10/2024
First Report Managed Care
News
Johnson & Johnson Expands Use of Prezcobix for Pediatric Patients in the US
06/21/2024
Johnson & Johnson aims to expand use of its HIV-1 therapy, Prezcobix, for younger patients in the US, potentially paving the way for improved treatment options for pediatric patients with the virus.
Johnson & Johnson aims to expand use of its HIV-1 therapy, Prezcobix, for younger patients in the US, potentially paving the way for improved treatment options for pediatric patients with the virus.
Johnson & Johnson aims to expand...
06/21/2024
First Report Managed Care
News
Long-Acting Injectable Antiretroviral Could "Help End AIDS"
08/15/2023
A coordinated effort involving governments, large funders, and manufacturers is essential for the rollout of long-acting and extended-delivery antiretroviral medication to effectively fight against the HIV epidemic, according to a commentary...
A coordinated effort involving governments, large funders, and manufacturers is essential for the rollout of long-acting and extended-delivery antiretroviral medication to effectively fight against the HIV epidemic, according to a commentary...
A coordinated effort involving...
08/15/2023
First Report Managed Care
News
Cost-Effectiveness of TB Preventive Treatment for People Living With HIV/AIDS
07/31/2023
Researchers investigated the cost-effectiveness of short-course tuberculosis preventive treatment among people living with HIV/AIDS (PLWHA) and household contacts.
Researchers investigated the cost-effectiveness of short-course tuberculosis preventive treatment among people living with HIV/AIDS (PLWHA) and household contacts.
Researchers investigated the...
07/31/2023
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
Cognitive Behavioral Therapy Improves Depressive Symptoms for People With HIV
12/12/2022
"This study aimed to systematically evaluate the effect of cognitive behavioral therapy on improving depressive symptoms and increasing adherence to antiretroviral therapy in people living with HIV," researchers said.
"This study aimed to systematically evaluate the effect of cognitive behavioral therapy on improving depressive symptoms and increasing adherence to antiretroviral therapy in people living with HIV," researchers said.
"This study aimed to...
12/12/2022
First Report Managed Care
News
More Than One-Third of Rural Adults With HIV Travel Over 1 Hour for Care
12/05/2022
Median travel times were 4 times longer for people with HIV living in rural areas compared to those in urban areas, findings showed. 
Median travel times were 4 times longer for people with HIV living in rural areas compared to those in urban areas, findings showed. 
Median travel times were 4 times...
12/05/2022
First Report Managed Care
News
Women With HIV Have Increased Risk of Chronic Kidney Disease
10/25/2022
It is critical to engage women with HIV in nephrology care to improve disease management and outcomes, researchers said.  
It is critical to engage women with HIV in nephrology care to improve disease management and outcomes, researchers said.  
It is critical to engage women...
10/25/2022
First Report Managed Care

Newsfeed

News
Addressing Stigma is Essential for Increasing PrEP Uptake and Adherence in HIV Prevention Efforts
09/20/2024
Addressing stigma associated with pre-exposure prophylaxis (PrEP) is crucial for improving its uptake and adherence among eligible populations, according to study results published in Sexes.
Addressing stigma associated with pre-exposure prophylaxis (PrEP) is crucial for improving its uptake and adherence among eligible populations, according to study results published in Sexes.
Addressing stigma associated...
09/20/2024
First Report Managed Care
News
CDC Invests $400 Million to Accelerate HIV Prevention and Surveillance Efforts Nationwide
09/16/2024
The Centers for Disease Control and Prevention (CDC) has awarded $400 million in funding to boost HIV prevention and surveillance efforts across the United States, aiming to accelerate progress in reducing new infections and improving health...
The Centers for Disease Control and Prevention (CDC) has awarded $400 million in funding to boost HIV prevention and surveillance efforts across the United States, aiming to accelerate progress in reducing new infections and improving health...
The Centers for Disease Control...
09/16/2024
First Report Managed Care
News
HIV Cases Rise Among Gay Latinos
07/24/2024
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise...
07/24/2024
First Report Managed Care
News
Machine Learning Approach Identifies HIV-1 Broadly Neutralizing Antibodies
07/10/2024
A computational method has been developed to identify HIV-1 broadly neutralizing antibodies (bNAbs) from non-selected immune repertoires, researchers reported in the journal Nature Communications.
A computational method has been developed to identify HIV-1 broadly neutralizing antibodies (bNAbs) from non-selected immune repertoires, researchers reported in the journal Nature Communications.
A computational method has been...
07/10/2024
First Report Managed Care
News
Johnson & Johnson Expands Use of Prezcobix for Pediatric Patients in the US
06/21/2024
Johnson & Johnson aims to expand use of its HIV-1 therapy, Prezcobix, for younger patients in the US, potentially paving the way for improved treatment options for pediatric patients with the virus.
Johnson & Johnson aims to expand use of its HIV-1 therapy, Prezcobix, for younger patients in the US, potentially paving the way for improved treatment options for pediatric patients with the virus.
Johnson & Johnson aims to expand...
06/21/2024
First Report Managed Care
News
Long-Acting Injectable Antiretroviral Could "Help End AIDS"
08/15/2023
A coordinated effort involving governments, large funders, and manufacturers is essential for the rollout of long-acting and extended-delivery antiretroviral medication to effectively fight against the HIV epidemic, according to a commentary...
A coordinated effort involving governments, large funders, and manufacturers is essential for the rollout of long-acting and extended-delivery antiretroviral medication to effectively fight against the HIV epidemic, according to a commentary...
A coordinated effort involving...
08/15/2023
First Report Managed Care
News
Cost-Effectiveness of TB Preventive Treatment for People Living With HIV/AIDS
07/31/2023
Researchers investigated the cost-effectiveness of short-course tuberculosis preventive treatment among people living with HIV/AIDS (PLWHA) and household contacts.
Researchers investigated the cost-effectiveness of short-course tuberculosis preventive treatment among people living with HIV/AIDS (PLWHA) and household contacts.
Researchers investigated the...
07/31/2023
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
Cognitive Behavioral Therapy Improves Depressive Symptoms for People With HIV
12/12/2022
"This study aimed to systematically evaluate the effect of cognitive behavioral therapy on improving depressive symptoms and increasing adherence to antiretroviral therapy in people living with HIV," researchers said.
"This study aimed to systematically evaluate the effect of cognitive behavioral therapy on improving depressive symptoms and increasing adherence to antiretroviral therapy in people living with HIV," researchers said.
"This study aimed to...
12/12/2022
First Report Managed Care
News
More Than One-Third of Rural Adults With HIV Travel Over 1 Hour for Care
12/05/2022
Median travel times were 4 times longer for people with HIV living in rural areas compared to those in urban areas, findings showed. 
Median travel times were 4 times longer for people with HIV living in rural areas compared to those in urban areas, findings showed. 
Median travel times were 4 times...
12/05/2022
First Report Managed Care
News
Using Deep Learning to Measure MS-Specific Brain Damage Beyond Aging
11/11/2024
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in...
11/11/2024
First Report Managed Care
News
Adverse Event Data Suggest Selective β1-blockers Pose Asthma Risk
11/11/2024
The risks of asthma and asthma-like adverse events appear to be higher with selective β1-blockers than with nonselective blockers and α- and β-blockers.
The risks of asthma and asthma-like adverse events appear to be higher with selective β1-blockers than with nonselective blockers and α- and β-blockers.
The risks of asthma and...
11/11/2024
First Report Managed Care
News
RNAi Therapies Offer New Hope for Patients With Hereditary Transthyretin Amyloidosis
11/08/2024
RNA interference (RNAi)-based treatments for hereditary transthyretin amyloidosis (ATTR) have shown remarkable promise, offering new hope for patients with this rare but devastating genetic disorder.
RNA interference (RNAi)-based treatments for hereditary transthyretin amyloidosis (ATTR) have shown remarkable promise, offering new hope for patients with this rare but devastating genetic disorder.
RNA interference (RNAi)-based...
11/08/2024
First Report Managed Care
News
Revolutionary Single-Dose Gene Therapy Offers New Hope for Adults with Hemophilia B
11/08/2024
A groundbreaking gene therapy for hemophilia B has shown remarkable success in reducing bleeding episodes and improving the quality of life for adult patients, according to a recent international phase III clinical trial.
A groundbreaking gene therapy for hemophilia B has shown remarkable success in reducing bleeding episodes and improving the quality of life for adult patients, according to a recent international phase III clinical trial.
A groundbreaking gene therapy...
11/08/2024
First Report Managed Care
News
Real-World Evidence Supports Efficacy and Safety of Selexipag in Patients With Pulmonary Arterial Hypertension
11/07/2024
Real-world data shows selexipag effectively improves functional class and risk category outcomes in patients with pulmonary arterial hypertension, regardless of maintenance dose.
Real-world data shows selexipag effectively improves functional class and risk category outcomes in patients with pulmonary arterial hypertension, regardless of maintenance dose.
Real-world data shows selexipag...
11/07/2024
First Report Managed Care
News
Clinical Predictors of One-Year Seizure Freedom After SLAH
11/06/2024
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of...
11/06/2024
First Report Managed Care
News
Efficacy and Outcomes of Neoadjuvant Immunotherapy in Lung Cancer
11/05/2024
A meta-analysis of 43 studies suggests that neoadjuvant chemoimmunotherapy may benefit patients with resectable NSCLC and low tumor PD-L1 levels for event-free survival, showing superior outcomes compared to neoadjuvant chemotherapy.
A meta-analysis of 43 studies suggests that neoadjuvant chemoimmunotherapy may benefit patients with resectable NSCLC and low tumor PD-L1 levels for event-free survival, showing superior outcomes compared to neoadjuvant chemotherapy.
A meta-analysis of 43 studies...
11/05/2024
First Report Managed Care
News
FDA Grants Accelerated Approval for Asciminib as First-Line Treatment in Ph+CML-CP
11/01/2024
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated...
11/01/2024
First Report Managed Care
News
HHS Faces Legal Action From 10 Hospitals Over 2023 Medicare Advantage Rule and Reimbursement Calculations
10/30/2024
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US...
10/30/2024
First Report Managed Care
News
Impact of Immune Checkpoint Inhibitors on Multiple Sclerosis Treatment Outcomes
10/29/2024
Relapses and progression of multiple sclerosis were rare in patients treated with immune checkpoint inhibitors, according to a study presented at the American Academy of Neurology 2024 Annual Meeting.
Relapses and progression of multiple sclerosis were rare in patients treated with immune checkpoint inhibitors, according to a study presented at the American Academy of Neurology 2024 Annual Meeting.
Relapses and progression of...
10/29/2024
First Report Managed Care

Insights
Interview
Clinical, Economic Impact of Adherence Interventions Among Youth With HIV
07/22/2021
Anne M Neilan, MD, MPH, medicine and pediatrics-trained adult infectious disease physician at Massachusetts General Hospital and instructor at Harvard Medical School, explains the results of her recent study that examined the impact of a...
Anne M Neilan, MD, MPH, medicine and pediatrics-trained adult infectious disease physician at Massachusetts General Hospital and instructor at Harvard Medical School, explains the results of her recent study that examined the impact of a...
Anne M Neilan, MD, MPH, medicine...
07/22/2021
First Report Managed Care
Examining the Correlation Between HIV Infection and Cognitive Impairment
Interview
Examining the Correlation Between HIV Infection and Cognitive Impairment
05/05/2021
Han-Zhu Qian, MD, PhD, MPH, explains the importance of screening cognitive functions and identifying the domains of cognitive impairment by age group among people living with HIV.
Han-Zhu Qian, MD, PhD, MPH, explains the importance of screening cognitive functions and identifying the domains of cognitive impairment by age group among people living with HIV.
Han-Zhu Qian, MD, PhD, MPH,...
05/05/2021
First Report Managed Care
Addressing Barriers to Preventive HIV Care for At-Risk Patient Populations
Podcasts
Addressing Barriers to Preventive HIV Care for At-Risk Patient Populations
01/25/2021
Ed Pezalla, MD, CEO, Enlightenment Bioconsult LLC, speaks about the barriers to preventive HIV care, pinpoints how payers can reach at-risk populations, and reviews the US Preventive Services Task Force’s measures requiring health plans to...
Ed Pezalla, MD, CEO, Enlightenment Bioconsult LLC, speaks about the barriers to preventive HIV care, pinpoints how payers can reach at-risk populations, and reviews the US Preventive Services Task Force’s measures requiring health plans to...
Ed Pezalla, MD, CEO,...
01/25/2021
First Report Managed Care
Examining a New Class of Antiretroviral Therapy for Patients With Multidrug-Resistant HIV-1 Infection
Videos
Examining a New Class of Antiretroviral Therapy for Patients With Multidrug-Resistant HIV-1 Infection
09/23/2020
Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class...
Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class...
Max Lataillade, DO, head of...
09/23/2020
First Report Managed Care

Related Content

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use